Journal Impact Factor 1.0* ; 1.93* (5 Year Impact Factor)
International Journal of Clinical Rheumatology is at the cutting edge of the most recent clinical, translational and lab based exploration to propel the treatment for a wide range of rheumatic diseases and disorders which includes themes, for example, treatment, surgery, imaging and clinical education.
The journal is committed to distribute most elevated quality studies identified with clinical determination and administration of rheumatic ailments through facilitated parts of clinical consideration and clinical examination concentrated on propelling treatment and personal satisfaction for individuals with joint pain, immune system infections, bone issue and related conditions. This journal offers an open access platform to Rheumatology community where, the authors can publish all the reliable sources of information on research findings and current developments as original articles, reviews, case studies, clinical images, short communications, commentaries, etc. and all the published materials will be accessed online all over the world without any subscription fee. The journal gives fundamental perusing to rheumatologists and additionally orthopedic specialists, pharmacologists, pathologists, radiologists, general experts and other wellbeing experts with an enthusiasm for patients with rheumatic maladies.
The journal also incorporates original papers inside the assorted fields of rheumatology, clinical experimentation as well as medicine, pathologic process, immunology, immunopathology, microbiology, clinical problems involving joints, soft tissues, auto-immune diseases, heritable connective tissue disorders and different types of radiological studies.
Indexing: Scimago, Excerpta Medica (EMBASE), CAS (Chemical Abstracts Service)
Submit your manuscripts through Editorial Manager: http://www.editorialmanager.com/openaccessjournals
Review Article p. 11
Author(s): Ciyuan Yu, Shuli Song & Juan Chen
Abstract: Interstitial lung disease (ILD) can lead to significant morbidity and excess mortality in systemic sclerosis (SSc) patients. The early identification of patients at risk of progres..
Research Article p. 20
Author(s): Charles A Inderjeeth & Warren D Raymond
Objective(s): To develop and evaluate age-stratified fracture risk score thresholds without dual X-ray absorptiometry (DXA) to manage osteoporosis. Methods: A multi-centered cohort study of..
Review Article p. 28
Author(s): Liliya Yankova Komsalova & Luis Morillas
Objective: To analyse clinical features, triggering diseases, treatment strategies and prognostic factors in patients with secondary haemophagosytic limphohistosytosis (SHLH). Methods: We r..
Case Report p. 38
Author(s): Mauricio Arraya, Yolanda Castro, Joaquin Navarro, Elizabeth Sarmiento, Eduardo Fernandez-Cruz & Javier Carbone Campoverde
Abstract: Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) is an inflammatory pulmonary complication of common variable immunodeficiency (CVID) with distinctive patterns in the bi..